CaPPRe has published a peer-reveiwed research paper on patient preferences for type 2 diabetes treatments. Using discrete choice experiment methodology, the findings showed that patients considered injection frequency, weight change and nausea to be important features of treatment. Patients were wiling to pay an additional $22.35 UAD/month for the benefits of a once-weekly injection over a twice-daily injection. 

In August 2017, we conducted a community value mapping study in 500 consumers  who had visited a pharmacy in the last 3 months. Participants were asked to evaluate their preferences for pharmacies offering different locations, opening hours, sevrices and cost. Results showed that there were 3 segments of consumers; those that were service driven, those that were access driven and those that were driven by loyalty. For more infromation about the study and our findings, see our infographic here. 

In August 2017 we conducted a pilot study to understand the community's preferences for genetic testing. We surveyed a representative sample of 500 people across Australia and asked them to evaulate different options for genetic testing in areas of cancer, arthritis, Alzheimer's disease, bipolar disorder and multiple sclerosis. Overall, 9 in 10 people said that they would do a genetic test to find out their risk factors for certain diseases. See our infographic to find out more.